Home » Topics » BioWorld Science

BioWorld Science
RSS

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Serono confirms submission of Rebif amendment to FDA

Oct. 15, 2001

Thyroid hormone receptor ligands in development at Pfizer

Oct. 11, 2001

Preparation and use of new beta3-adrenoceptor agonists covered in recent patent

Oct. 11, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Dainippon compounds with benzodiazepine receptor subtype selectivity

Oct. 11, 2001

Oxamide-based inhibitors of IMPDH under study at Roche

Oct. 11, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Xenova terminates TA-HSV development, DISC-PRO studies continue

Oct. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...